drugset / Trial / NCT05095519

Hepatocellular Carcinoma Imaging Using PSMA PET/CT

NCT05095519

Phase 2 Active not recruiting 30 enrolled Peter MacCallum Cancer Centre, Australia
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of the research is to evaluate the use of a PSMA PET/CT (Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography) scan in the diagnosis of HCC (hepatocellular carcinoma) and comparing it to standard scanning techniques with CT (Computed Tomography) or MRI (Magnetic Resonance Imaging).

Timeline

Start
2021-09-08
Primary completion
2026-03-08
Completion
2026-09-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DCFPyL Diagnostic / imaging agent 3.5 mbq/kg Intravenous